Carregant...

Pneumococcal Vaccination in Adults Aged ≥65 Years: Cost Effectiveness and Health Impact in U.S. Populations

INTRODUCTION: Recommending both the conjugate and polysaccharide pneumococcal vaccines to all U.S. seniors may have little public health impact and be economically unreasonable. Public health impact and cost effectiveness of using both vaccines in all adults aged ≥65 years were estimated compared wi...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Am J Prev Med
Autors principals: Wateska, Angela R., Nowalk, Mary Patricia, Lin, Chyongchiou J., Harrison, Lee H., Schaffner, William, Zimmerman, Richard K., Smith, Kenneth J.
Format: Artigo
Idioma:Inglês
Publicat: 2020
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7089827/
https://ncbi.nlm.nih.gov/pubmed/32001052
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.amepre.2019.10.022
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!